Cymbalta Medication Profile
Profile of the selective serotonin norepinephrine reuptake inhibitor Cymbalta - generic duloxetine hydrochloride - which is prescribed for the treatment of major depression and the pain associated with diabetic neuropathy, as well as some significant off-label uses including bipolar disorder and fibromyalgia.
Cymbalta Side Effects
Cymbalta / Duloxetine is an antidepressant medication that is also used to treat diabetic neuropathy. It is classed as an SNRI - Serotonin-Norepinephrine Reuptake Inhibitor. It is used to treat depressive symptoms including the aches and pains that can be caused by depression. This page lists the best-known Cymbalta side effects.
Drug Profile - Duloxetine (Cymbalta)
Nancy Schimelpfening, the About Guide to Depression, offers a concise, easy to understand profile of this medication.
Cymbalta Gets Mixed Reception
Eli Lilly's new antidepressant Cymbalta should be hitting the streets in the U.S. The company hopes that it has found a money-maker, since it's flagship antidepressant Prozac is now available in a cheaper generic version.
RxList offers a comprehensive monograph for this medication including chemistry, chemical structure and inactive ingredients as well warnings and side effects.
Cymbalta - The Crazy Meds Rundown
A user's perspective of Cymbalta, along with an interpretation of the PI (prescribing information) sheet.
Cymbalta Gets Europe Go-Ahead
A revolutionary new treatment for depression has been granted marketing authorisation by the European Commission. The new therapy is said to be able to treat the full spectrum of depressive symptoms.
Cymbalta Helped Patients with Depression Feel Better
Patients treated successfully with 60 mg per day of the investigational antidepressant Cymbalta? (duloxetine hydrochloride), were less likely to have their emotional and physical symptoms of depression return than those who stopped taking medication after beginning to feel better, according to results of a 38-week study.
Duloxetine in the Treatment of Depression
A study reported in the August 2004 edition of the Journal of Clinical Psychopharmacology found that duloxetine therapy was efficacious for emotional and physical symptoms of depression, with a selective serotonin reuptake inhibitor-like profile of side effects.